Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias
Authors:
- Roop LalRLRoop Lal
- Peter D. ChapmanPCPeter D. Chapman
- Gerald V. NaccarrelliGNGerald V. Naccarrelli
- Paul J. TroupPTPaul J. Troup
- Robert L. RinkenbergerRRRobert L. Rinkenberger
- Anne H. DoughertyADAnne H. Dougherty
- Rodolphe RuffyRRRodolphe Ruffy
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac deathThe American Journal of Cardiology, 1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: Summary of long-term follow-upThe American Journal of Cardiology, 1984
- Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: Evidence for exacerbation of electrical instabilityThe American Journal of Cardiology, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasThe American Journal of Cardiology, 1983
- Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart diseaseThe American Journal of Cardiology, 1983
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981